A Core set of patient‐reported outcome measures to measure quality of life in obesity treatment research

Phillip J. Dijkhorst; Claire E. E. de Vries; Caroline B. Terwee; Ignace M. C. Janssen; Ronald S. L. Liem; Bart A. van Wagensveld; Johan Ottosson; Bruno Halpern; Stuart W. Flint; Elisabeth F.C. van Rossum; Alend Saadi; Lisa West-Smith; Mary O’Kane; Jason C.G. Halford; Karen D. Coulman; Salman Al-Sabah; John B. Dixon; Wendy A. Brown; Ximena Ramos Salas; Maarten M. Hoogbergen; Sally Abbott; Alyssa J. Budin; Jennifer F. Holland; Lotte Poulsen; Richard Welbourn; Bernardo Rea Ruanova; John M. Morton; Francois Pattou; Erman O. Akpinar; Stephanie Sogg; Jacques M. Himpens; Vanessa Osborne; Natasja Wijling; Laura Divine; Nadya Isack; Susie Birney; J. M. Bernadette Keenan; Joe Nadglowski; Jacqueline Bowman; Ken Clare; Riccardo Meloni; Sandra de Blaeij; Theodore K. Kyle; Melanie Bahlke; Andrew Healing; Ian Patton; Valerie M. Monpellier

doi:10.1111/obr.13849

A Core set of patient‐reported outcome measures to measure quality of life in obesity treatment research

Phillip J. Dijkhorst
, Claire E. E. de Vries
, Caroline B. Terwee
, Ignace M. C. Janssen
, Ronald S. L. Liem
, Bart A. van Wagensveld
, Johan Ottosson
, Bruno Halpern
, Stuart W. Flint
, Elisabeth F.C. van Rossum
, Alend Saadi
, Lisa West-Smith
, Mary O’Kane
, Jason C.G. Halford
, Karen D. Coulman
, Salman Al-Sabah
, John B. Dixon
, Wendy A. Brown
, Ximena Ramos Salas
, Maarten M. Hoogbergen

Sally Abbott, Alyssa J. Budin, Jennifer F. Holland, Lotte Poulsen, Richard Welbourn, Bernardo Rea Ruanova, John M. Morton, Francois Pattou, Erman O. Akpinar, Stephanie Sogg, Jacques M. Himpens, Vanessa Osborne, Natasja Wijling, Laura Divine, Nadya Isack, Susie Birney, J. M. Bernadette Keenan, Joe Nadglowski, Jacqueline Bowman, Ken Clare, Riccardo Meloni, Sandra de Blaeij, Theodore K. Kyle, Melanie Bahlke, Andrew Healing, Ian Patton, Valerie M. Monpellier

OLVG
VU University Amsterdam
Nederlandse Obesitas Kliniek
Erasmus University Medical Center
Neuchâtel Hospital
University of Lausanne
University of Cincinnati College of Medicine
Leeds Teaching Hospitals NHS Trust
University of Leeds
Kuwait University
Swinburne University of Technology
Monash University
Obesity Canada
European Association for the Study of Obesity
University of Southern Denmark
Musgrove Park Hospital
Dutch Association for Overweight and Obesity
People Living With Obesity Representative
Obesity Empowerment Network
European Coalition for People Living With Obesity
The Belgian Foundation for the Rights of People living with obesity
Obesity Action Coalition
Adipositascirurgie Selbsthilfe Deutschland E.V.
Groene Hart Ziekenhuis
NMC Royal Hospital
Örebro University
Hospital Nove de Julho
Brazilian Association for the Study of Obesity
NIHR Bristol Biomedical Research Centre
University of Bristol
Catharina Ziekenhuis
University Hospitals Coventry and Warwickshire NHS Trust
Odense University Hospital
Lontoft, Nyhoj and Poulsen Plastic Surgery
Yale School of Medicine
Centre Hospitalier Universitaire de Lille
University of Lille
Maastricht University
Harvard Medical School
Delta Hospital
North Tees and Hartlepool NHS Foundation Trust
Irish Coalition for People Living with Obesity
Leeds Beckett University
KleinePorties

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

17 Downloads (Pure)

Abstract

The lack of standardization in patient‐reported outcome measures (PROMs) has made measurement and comparison of quality of life (QoL) outcomes in research focused on obesity treatment challenging. This study reports on the results of the second and third global multidisciplinary Standardizing Quality of life measures in Obesity Treatment (S.Q.O.T.) consensus meetings, where a core set of PROMs to measure nine previously selected patient‐reported outcomes (PROs) in obesity treatment research was established. The S.Q.O.T. II online and S.Q.O.T. III face‐to‐face hybrid consensus meetings were held in October 2021 and May 2022. The meetings were led by an independent moderator specializing in PRO measurement. Nominal group techniques, Delphi exercises, and anonymous voting were used to select the most suitable PROMs by consensus. The meetings were attended by 28 and 27 participants, respectively, including a geographically diverse selection of people living with obesity (PLWO) and experts from various disciplines.Out of 24 PROs and 16 PROMs identified in the first S.Q.O.T. consensus meeting, the following nine PROs and three PROMs were selected via consensus: BODY‐Q (physical function, physical symptoms, psychological function, social function, eating behavior, and body image), IWQOL‐Lite (self‐esteem), and QOLOS (excess skin). No PROM was selected to measure stigma as existing PROMs deemed to be inadequate. A core set of PROMs to measure QoL in research focused on obesity treatment has been selected incorporating patients' and experts' opinions. This core set should serve as a minimum to use in obesity research studies and can be combined with clinical parameters.

Original language	English
Article number	e13849
Pages (from-to)	(In-Press)
Number of pages	11
Journal	Obesity Reviews
Volume	26
Issue number	2
Early online date	17 Oct 2024
DOIs	https://doi.org/10.1111/obr.13849
Publication status	E-pub ahead of print - 17 Oct 2024

Funder

The S.Q.O.T. II meeting was funded by Medtronic, Johnson and Johnson, Philips Vital Health, Novo Nordisk, Castor, and Bart Torensma. The S.Q.O.T. III meeting was funded by Medtronic, Johnson and Johnson, Novo Nordisk, Goodlife, and Fitforme. The funders of the meeting were not involved in the selection of the PROs or PROMs. None of the members of the S.Q.O.T. organizing committee (PD, CV, VM, BW, IJ, and RL) and none of the participants of the consensus meetings received payment for their participation. Meeting spaces, audiovisual support, catering, travel expenses, and the hotel overnight for the meetings were supported by Johnson and Johnson (S.Q.O.T. II) and Medtronic, Johnson and Johnson, Novo Nordisk, Goodlife, and Fitforme (S.Q.O.T. III). Additionally, the moderator costs (CT) were supported by these sponsors. The sponsors played no role in the selection of participants of the meeting, in the selection of the domains and questionnaires included in this meeting, the voting rounds, or the writing of this paper, nor in any other research related activity. The S.Q.O.T. organizing committee (PD, CV, VM, BW, IJ, and RL) did not receive payment for their work for the S.Q.O.T. initiative.

Funding

The S.Q.O.T. II meeting was funded by Medtronic, Johnson and Johnson, Philips Vital Health, Novo Nordisk, Castor, and Bart Torensma. The S.Q.O.T. III meeting was funded by Medtronic, Johnson and Johnson, Novo Nordisk, Goodlife, and Fitforme. The funders of the meeting were not involved in the selection of the PROs or PROMs. None of the members of the S.Q.O.T. organizing committee (PD, CV, VM, BW, IJ, and RL) and none of the participants of the consensus meetings received payment for their participation. Meeting spaces, audiovisual support, catering, travel expenses, and the hotel overnight for the meetings were supported by Johnson and Johnson (S.Q.O.T. II) and Medtronic, Johnson and Johnson, Novo Nordisk, Goodlife, and Fitforme (S.Q.O.T. III). Additionally, the moderator costs (CT) were supported by these sponsors. The sponsors played no role in the selection of participants of the meeting, in the selection of the domains and questionnaires included in this meeting, the voting rounds, or the writing of this paper, nor in any other research related activity. The S.Q.O.T. organizing committee (PD, CV, VM, BW, IJ, and RL) did not receive payment for their work for the S.Q.O.T. initiative.

Funders
Medtronic
Johnson & Johnson
Philips
Novo Nordisk
Castor EDC
Goodlife
Fitforme

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

bariatric surgery
obesity treatment
patient-reported outcome
quality of life

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health
Endocrinology, Diabetes and Metabolism

Access to Document

10.1111/obr.13849

Accepted manuscript Accepted author manuscript, 635 KB

Cite this

Dijkhorst, P. J., Vries, C. E. E. D., Terwee, C. B., Janssen, I. M. C., Liem, R. S. L., Wagensveld, B. A. V., Ottosson, J., Halpern, B., Flint, S. W., van Rossum, E. F. C., Saadi, A., West-Smith, L., O’Kane, M., Halford, J. C. G., Coulman, K. D., Al-Sabah, S., Dixon, J. B., Brown, W. A., Ramos Salas, X., ... Monpellier, V. M. (2024). A Core set of patient‐reported outcome measures to measure quality of life in obesity treatment research. Obesity Reviews, 26(2), (In-Press). Article e13849. Advance online publication. https://doi.org/10.1111/obr.13849

Dijkhorst, PJ, Vries, CEED, Terwee, CB, Janssen, IMC, Liem, RSL, Wagensveld, BAV, Ottosson, J, Halpern, B, Flint, SW, van Rossum, EFC, Saadi, A, West-Smith, L, O’Kane, M, Halford, JCG, Coulman, KD, Al-Sabah, S, Dixon, JB, Brown, WA, Ramos Salas, X, Hoogbergen, MM, Abbott, S, Budin, AJ, Holland, JF, Poulsen, L, Welbourn, R, Rea Ruanova, B, Morton, JM, Pattou, F, Akpinar, EO, Sogg, S, Himpens, JM, Osborne, V, Wijling, N, Divine, L, Isack, N, Birney, S, Keenan, JMB, Nadglowski, J, Bowman, J, Clare, K, Meloni, R, Blaeij, SD, Kyle, TK, Bahlke, M, Healing, A, Patton, I & Monpellier, VM 2024, 'A Core set of patient‐reported outcome measures to measure quality of life in obesity treatment research', Obesity Reviews, vol. 26, no. 2, e13849, pp. (In-Press). https://doi.org/10.1111/obr.13849

@article{962605052cd74da7a685dca87dfcc676,

title = "A Core set of patient‐reported outcome measures to measure quality of life in obesity treatment research",

abstract = "The lack of standardization in patient‐reported outcome measures (PROMs) has made measurement and comparison of quality of life (QoL) outcomes in research focused on obesity treatment challenging. This study reports on the results of the second and third global multidisciplinary Standardizing Quality of life measures in Obesity Treatment (S.Q.O.T.) consensus meetings, where a core set of PROMs to measure nine previously selected patient‐reported outcomes (PROs) in obesity treatment research was established. The S.Q.O.T. II online and S.Q.O.T. III face‐to‐face hybrid consensus meetings were held in October 2021 and May 2022. The meetings were led by an independent moderator specializing in PRO measurement. Nominal group techniques, Delphi exercises, and anonymous voting were used to select the most suitable PROMs by consensus. The meetings were attended by 28 and 27 participants, respectively, including a geographically diverse selection of people living with obesity (PLWO) and experts from various disciplines.Out of 24 PROs and 16 PROMs identified in the first S.Q.O.T. consensus meeting, the following nine PROs and three PROMs were selected via consensus: BODY‐Q (physical function, physical symptoms, psychological function, social function, eating behavior, and body image), IWQOL‐Lite (self‐esteem), and QOLOS (excess skin). No PROM was selected to measure stigma as existing PROMs deemed to be inadequate. A core set of PROMs to measure QoL in research focused on obesity treatment has been selected incorporating patients' and experts' opinions. This core set should serve as a minimum to use in obesity research studies and can be combined with clinical parameters.",

keywords = "bariatric surgery, obesity treatment, patient-reported outcome, quality of life",

author = "Dijkhorst, \{Phillip J.\} and Vries, \{Claire E. E. de\} and Terwee, \{Caroline B.\} and Janssen, \{Ignace M. C.\} and Liem, \{Ronald S. L.\} and Wagensveld, \{Bart A. van\} and Johan Ottosson and Bruno Halpern and Flint, \{Stuart W.\} and \{van Rossum\}, \{Elisabeth F.C.\} and Alend Saadi and Lisa West-Smith and Mary O{\textquoteright}Kane and Halford, \{Jason C.G.\} and Coulman, \{Karen D.\} and Salman Al-Sabah and Dixon, \{John B.\} and Brown, \{Wendy A.\} and \{Ramos Salas\}, Ximena and Hoogbergen, \{Maarten M.\} and Sally Abbott and Budin, \{Alyssa J.\} and Holland, \{Jennifer F.\} and Lotte Poulsen and Richard Welbourn and \{Rea Ruanova\}, Bernardo and Morton, \{John M.\} and Francois Pattou and Akpinar, \{Erman O.\} and Stephanie Sogg and Himpens, \{Jacques M.\} and Vanessa Osborne and Natasja Wijling and Laura Divine and Nadya Isack and Susie Birney and Keenan, \{J. M. Bernadette\} and Joe Nadglowski and Jacqueline Bowman and Ken Clare and Riccardo Meloni and Blaeij, \{Sandra de\} and Kyle, \{Theodore K.\} and Melanie Bahlke and Andrew Healing and Ian Patton and Monpellier, \{Valerie M.\}",

year = "2024",

month = oct,

day = "17",

doi = "10.1111/obr.13849",

language = "English",

volume = "26",

pages = "(In--Press)",

journal = "Obesity Reviews",

issn = "1467-7881",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - A Core set of patient‐reported outcome measures to measure quality of life in obesity treatment research

AU - Dijkhorst, Phillip J.

AU - Vries, Claire E. E. de

AU - Terwee, Caroline B.

AU - Janssen, Ignace M. C.

AU - Liem, Ronald S. L.

AU - Wagensveld, Bart A. van

AU - Ottosson, Johan

AU - Halpern, Bruno

AU - Flint, Stuart W.

AU - van Rossum, Elisabeth F.C.

AU - Saadi, Alend

AU - West-Smith, Lisa

AU - O’Kane, Mary

AU - Halford, Jason C.G.

AU - Coulman, Karen D.

AU - Al-Sabah, Salman

AU - Dixon, John B.

AU - Brown, Wendy A.

AU - Ramos Salas, Ximena

AU - Hoogbergen, Maarten M.

AU - Abbott, Sally

AU - Budin, Alyssa J.

AU - Holland, Jennifer F.

AU - Poulsen, Lotte

AU - Welbourn, Richard

AU - Rea Ruanova, Bernardo

AU - Morton, John M.

AU - Pattou, Francois

AU - Akpinar, Erman O.

AU - Sogg, Stephanie

AU - Himpens, Jacques M.

AU - Osborne, Vanessa

AU - Wijling, Natasja

AU - Divine, Laura

AU - Isack, Nadya

AU - Birney, Susie

AU - Keenan, J. M. Bernadette

AU - Nadglowski, Joe

AU - Bowman, Jacqueline

AU - Clare, Ken

AU - Meloni, Riccardo

AU - Blaeij, Sandra de

AU - Kyle, Theodore K.

AU - Bahlke, Melanie

AU - Healing, Andrew

AU - Patton, Ian

AU - Monpellier, Valerie M.

PY - 2024/10/17

Y1 - 2024/10/17

N2 - The lack of standardization in patient‐reported outcome measures (PROMs) has made measurement and comparison of quality of life (QoL) outcomes in research focused on obesity treatment challenging. This study reports on the results of the second and third global multidisciplinary Standardizing Quality of life measures in Obesity Treatment (S.Q.O.T.) consensus meetings, where a core set of PROMs to measure nine previously selected patient‐reported outcomes (PROs) in obesity treatment research was established. The S.Q.O.T. II online and S.Q.O.T. III face‐to‐face hybrid consensus meetings were held in October 2021 and May 2022. The meetings were led by an independent moderator specializing in PRO measurement. Nominal group techniques, Delphi exercises, and anonymous voting were used to select the most suitable PROMs by consensus. The meetings were attended by 28 and 27 participants, respectively, including a geographically diverse selection of people living with obesity (PLWO) and experts from various disciplines.Out of 24 PROs and 16 PROMs identified in the first S.Q.O.T. consensus meeting, the following nine PROs and three PROMs were selected via consensus: BODY‐Q (physical function, physical symptoms, psychological function, social function, eating behavior, and body image), IWQOL‐Lite (self‐esteem), and QOLOS (excess skin). No PROM was selected to measure stigma as existing PROMs deemed to be inadequate. A core set of PROMs to measure QoL in research focused on obesity treatment has been selected incorporating patients' and experts' opinions. This core set should serve as a minimum to use in obesity research studies and can be combined with clinical parameters.

AB - The lack of standardization in patient‐reported outcome measures (PROMs) has made measurement and comparison of quality of life (QoL) outcomes in research focused on obesity treatment challenging. This study reports on the results of the second and third global multidisciplinary Standardizing Quality of life measures in Obesity Treatment (S.Q.O.T.) consensus meetings, where a core set of PROMs to measure nine previously selected patient‐reported outcomes (PROs) in obesity treatment research was established. The S.Q.O.T. II online and S.Q.O.T. III face‐to‐face hybrid consensus meetings were held in October 2021 and May 2022. The meetings were led by an independent moderator specializing in PRO measurement. Nominal group techniques, Delphi exercises, and anonymous voting were used to select the most suitable PROMs by consensus. The meetings were attended by 28 and 27 participants, respectively, including a geographically diverse selection of people living with obesity (PLWO) and experts from various disciplines.Out of 24 PROs and 16 PROMs identified in the first S.Q.O.T. consensus meeting, the following nine PROs and three PROMs were selected via consensus: BODY‐Q (physical function, physical symptoms, psychological function, social function, eating behavior, and body image), IWQOL‐Lite (self‐esteem), and QOLOS (excess skin). No PROM was selected to measure stigma as existing PROMs deemed to be inadequate. A core set of PROMs to measure QoL in research focused on obesity treatment has been selected incorporating patients' and experts' opinions. This core set should serve as a minimum to use in obesity research studies and can be combined with clinical parameters.

KW - bariatric surgery

KW - obesity treatment

KW - patient-reported outcome

KW - quality of life

UR - https://www.scopus.com/pages/publications/85206836706

U2 - 10.1111/obr.13849

DO - 10.1111/obr.13849

M3 - Article

SN - 1467-7881

VL - 26

SP - (In-Press)

JO - Obesity Reviews

JF - Obesity Reviews

IS - 2

M1 - e13849

ER -

A Core set of patient‐reported outcome measures to measure quality of life in obesity treatment research

Abstract

Funder

Funding

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this